ALGESAL SURACTIVE

This brand name is authorized in Austria, France, Tunisia, Turkey.

Active ingredients

The drug ALGESAL SURACTIVE contains a combination of these active pharmaceutical ingredients (APIs):

1
UNII 5V7PT38BJU - DIETHYLAMINE SALICYLATE
 

Diethylamine salicylate is a topical analgesic, with the anti-inflammatory properties of salicylates. It is believed to exert cortisone-like action, stimulating the pituitary-adrenal axis, exerting an analgesic and anti-inflammatory effect.

 
Read more about Diethylamine salicylate
2
UNII 9902116282 - MYRTECAINE
 

Myrtecaine is a local anaesthetic. It is used to treat muscle strains, tendinitis or ligament sprains and joint pain. It is a surface anaesthetic, adds to the analgesic and anti-inflammatory actions of diethylamine salicylate by facilitating its penetration. Also myrtecaine has a muscle relaxant effect.

 
Read more about Myrtecaine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
M02AC Preparations with salicylic acid derivatives M Musculo-skeletal system → M02 Topical products for joint and muscular pain → M02A Topical products for joint and muscular pain
Discover more medicines within M02AC
P02DA Salicylic acid derivatives P Antiparasitic products, insecticides and repellents → P02 Anthelmintics → P02D Anticestodals
Discover more medicines within P02DA

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
FR Base de données publique des médicaments 67638519
TR İlaç ve Tıbbi Cihaz Kurumu 8699559380026

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.